Variability in delivered dose and respirable delivered dose from nebulizers: are current regulatory testing guidelines sufficient to produce meaningful information?

@inproceedings{Hatley2017VariabilityID,
  title={Variability in delivered dose and respirable delivered dose from nebulizers: are current regulatory testing guidelines sufficient to produce meaningful information?},
  author={Ross H M Hatley and Sarah M Byrne},
  booktitle={Medical devices},
  year={2017}
}
BACKGROUND To improve convenience to patients, there have been advances in the operation of nebulizers, resulting in fast treatment times and less drug lost to the environment. However, limited attention has been paid to the effects of these developments on the delivered dose (DD) and respirable delivered dose (RDD). Published pharmacopoeia and ISO testing… CONTINUE READING